During the State Fiscal Year (FY) 2021-2022, Florida State Attorney General Ashley Moody announced a series of historic settlements between the State of Florida and the manufacturers, distributors, and dispensers of opioids that will provide more than $3 billion to Florida over the next eighteen years.
 
At the July 1, 2021, Regular Council Meeting, Palm Bay City Council adopted Resolution 2021-33 which recognized the harmful effects from the opioid epidemic suffered by the City. The City of Palm Bay joined the State of Florida, counties, and other cities as part of the filed action in re: National Prescription Opiate Litigation, MDL No. 2804 (N.D. Ohio) (the “Opioid Litigation”). Resolution 2021-33 proposed a unified plan for the allocation and use of prospective settlement dollars from opioid related litigation, and the City entered into a Memorandum of Understanding (MOU) with the State of Florida setting the framework of the unified plan for the proposed allocation and use of opioid settlement proceeds.

In February of 2023, Governor Ron DeSantis announced plans for the first $205.7 million from the Opioid Settlements. In year one, these funds will serve communities throughout the State of Florida, and support prevention, treatment, and recovery efforts statewide.

On November 15, 2021, the Office of the Attorney General executed a Florida Opioid Allocation and Statewide Response Agreement (see Attachment A of this RFA) with certain local government in the State of Florida prescribing the intent of the State and local governments for use of the opioid settlement proceeds and provided for Exhibits “A” (herein after referred to as ‘Schedule A’) and “B” (hereinafter referred to as ‘Schedule B’) of the Agreement to ensure that the funds are expended in compliance with evolving evidence-based best practices. Eligible use of opioid settlement funds must fall under one of the three categories established in Schedule B: Treatment, Prevention, and Other Strategies. Core strategies shall comply with Schedule A.

In December of 2023, the City received the first round of the National Opioid Settlement funds from some of the largest pharmaceutical distributors Allergen, CVS, Distributors, Janssen, Teva, Walgreens and Walmart (“Distributors”).  The City will continue to receive funds until December 2036.  The City has received opioid settlement proceeds totaling $275,619.36, which includes $86,397.57 (FY 2023) and $189,221.79 (FY 2024). Per the Agreement, the City is authorized to withhold a maximum of five percent (5% or a total of $13,780.97 for both FYs combined) to cover administrative costs, which leaves a balance of $261,838.39 in opioid settlement funds to be awarded under this Opioid Settlement Proceeds Grant.

Request for Applications FY 23-24 Opioid Settlement Proceeds Grant (OSPG)

At the Regular Council Meeting on July 18, 2024, Palm Bay City Council authorized the City to publish a Request for Applications to solicit applications for use of FY 2023 and 2024 opioid settlement proceeds.

• Request for Applications FY 23-24 Opioid Settlement Proceeds Grant (OSPG)
• Addendum #1
• Attachment A- FL Opioids Allocation & SW Resp Agreement with Exhibits
• Attachment B – Section VII
• Resolution 2021-33
• Mandatory Technical Assistance Workshop Meeting Recording

Addendum #1

This first addendum is being issued in an effort to provide equity for all applicants since the mandatory technical assistance workshop scheduled on August 23, 2024, was postponed to August 30, 2024.

Question: Will the City hold another technical assistance workshop for agencies who missed the virtual mandatory technical assistance workshop originally scheduled for August 23, 2024?

Registration form must be completed by Thursday, August 29, 2024 by 12 noon. Form located here: www.pbfl.org/opioid

Answer: The City will record the technical assistance workshop scheduled for Friday, August 30, 2024, at 10am. The recording can be found here www.pbfl.org/opioid. Agencies not available to attend can watch the recording. In addition to watching the mandatory technical assistance workshop, applicants shall also complete a self-certification form. The self-certification form can be found on the opioid website here www.pbfl.org/opioid. By completing and submitting the self-certification form, applicants certify they have reviewed the recording from the Mandatory Technical Assistance Workshop. This form is required to be completed and included in the application packet for all agencies that were not able attend the workshop.

• Self Certification Opioid RFA

Question: Can agencies attend a council meeting virtually for the presentation?

Answer:  No.  In the past, Council has asked staff to ensure all presentations are in person. They do not prefer virtual.

Question:  Can an agency apply for the Opioid Grant as a lead agency, and also be listed on another application as a service provider under another lead agency?  

Answer: Yes. An agency may submit their application as the lead, and also be listed as a service provider under another lead agency.